ArticleInternational journal of surgery case reports2025
Laparoscopic resection of a retroperitoneal schwannoma posterior to the renal artery.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRetroperitoneal schwannoma is usually asymptomatic, and is often found incidentally during physical examination. It is easy to be misdiagnosed as paraganglioma, retroperitoneal malignant tumor and giant lymphocyte hyperplasia. Accurate preoperative diagnosis is helpful for clinicians to make surgical plans and preoperative preparations. This paper reports a case of retroperitoneal schwannoma. Preoperative imaging suggested a neurogenic tumor behind the left renal artery. The treatment was laparoscopic retroperitoneal tumor resection. The postoperative pathological diagnosis was retroperitoneal schwannoma. CASE PRESENTATION: The 52-year-old female patient was admitted to the hospital due to a left retroperitoneal tumor. Preoperative CT and MRI showed neurogenic tumor. After patient authorization, left retroperitoneal tumor resection was performed under laparoscopy. The postoperative pathological diagnosis was retroperitoneal schwannoma. The patient was followed up for 1 year without recurrence or metastasis. CLINICAL DISCUSSION: The CT features of retroperitoneal schwannoma may be lower than that of the muscle tissue at the same level, with uneven density, cystic lesions, hemorrhage, calcification and other characteristics. Enhanced CT can show progressive enhancement, mild to moderate enhancement in the arterial phase and moderate enhancement in the delayed phase. MRI showed slightly high signal intensity in the center of T2WI lesions, obvious high signal intensity at the edge, and high signal intensity on DWI. The diagnosis of retroperitoneal schwannoma depends on postoperative pathological examination. S-100 protein is one of its specific markers, and most of them are positive. Retroperitoneal schwannoma is mostly benign, but there are also some patients with malignant tumors. The first choice of treatment is complete resection of the tumor, and the tumor margin can also be negative by removing part of the normal adjacent tissue. The survival rate of patients with complete resection can reach 100 %, and the recurrence rate of patients with incomplete resection is about 5-10 %.
conclusionRetroperitoneal schwannoma is a relatively rare retroperitoneal tumor. Enhanced CT can show progressive enhancement, mild to moderate enhancement in the arterial phase and moderate enhancement in the delayed phase. MRI showed slightly high signal intensity in the center of T2WI lesions, obvious high signal intensity at the edge, and high signal intensity on DWI. The diagnosis of retroperitoneal schwannoma depends on postoperative pathological examination, and S-100 protein is one of its specific markers. Retroperitoneal schwannoma is mostly benign, but there are also some malignant tumors. The treatment of retroperitoneal schwannoma is the first choice to completely remove the tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.